Noa Shelach
Algemeen Directeur bij Lutris Pharma Ltd.
Actieve functies van Noa Shelach
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | - | - |
Loopbaan van Noa Shelach
Eerdere bekende functies van Noa Shelach
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Algemeen Directeur | - | - |
| NEXTGEN BIOMED LTD | Algemeen Directeur | 13-02-2014 | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Directeur/Bestuurslid | - | - |
Opleiding van Noa Shelach
| The Hebrew University of Jerusalem | Doctorate Degree |
Statistieken
Internationaal
| Israël | 6 |
Operationeel
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Miscellaneous | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEXTGEN BIOMED LTD | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Integra Holdings Ltd.
Integra Holdings Ltd. MiscellaneousMiscellaneous Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel. | Miscellaneous |
Lutris Pharma Ltd.
Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Health Technology |
- Beurs
- Insiders
- Noa Shelach
- Ervaring
